Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BIOAF - Bioasis enters into research collaboration with Janssen for its xB3 platform

BIOAF - Bioasis enters into research collaboration with Janssen for its xB3 platform

Bioasis Technologies Inc
Biopharmaceutical company Bioasis Technologies (OTCQB:BIOAF) on Monday entered into a research collaboration with Johnson & Johnson's (JNJ) Janssen Biotech. As per the agreement, Janssen will have the option to research, develop and commercialize products based on Bioasis' xB3 platform. The xB3 platform is a technology developed by Bioasis for the delivery of therapeutics across the blood-brain barrier in the treatment of several central nervous system and neurological disorders.

For further details see:

Bioasis enters into research collaboration with Janssen for its xB3 platform
Stock Information
Company Name: Bioasis Technologies Inc
Stock Symbol: BIOAF
Market: OTC
Website: bioasis.us
Menu
BIOAF BIOAF Quote BIOAF Short BIOAF News BIOAF Articles BIOAF Message Board
Get BIOAF Alerts

News, Short Squeeze, Breakout and More Instantly...